source
- Israeli biotech's inhaled exosome therapy cuts respiratory failure and mortality in ARDS phase 2b trialNano24, an Israeli biotech company, tested its inhaled exosome product EXO‑CD24 in a mid‑stage study involving 90 patients with acute respiratory distress syndrome. The trial compared the therapy,…
- Sanofi breaks ground on Frankfurt insulin API plant with €400 million German aidSanofi has started construction of a new insulin active pharmaceutical ingredient (API) manufacturing facility at its Frankfurt site in Germany. The plant, covering about 36,000 square meters, is…